Remove Books Remove Pharmaceutical Remove Sourcing
article thumbnail

Mushiny Intelligent 3D Sorter receives RBR50 award for logistics innovation

Robotics Business Review

Source: Mushiny WTWH Media has named Mushiny Co. The 2024 RBR50 Robotics Innovation Awards have recognized the Mushiny Intelligent 3D Sorter. a 2024 RBR50 Robotics Innovation Award winner this month. It recognized the Suzhou, China-based company for its Intelligent 3D Sorter as an innovative technology.

Logistics 110
article thumbnail

CoreTigo and Raven.ai Partner to Elevate Manufacturing Efficiency and OEE

Fabricating & Metal Work

With actionable insights from combined human and machine sources, manufacturers are empowered to optimize production processes, reduce downtime and boost revenue generation. Combined, these have shown even greater value for early adaptor customers, including a leading USA-based pharmaceutical manufacturer. The post CoreTigo and Raven.ai

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CoreTigo and Raven.ai Partner to Elevate Manufacturing Efficiency and OEE Through Advanced Technology Integration

i4.0 today

With actionable insights from combined human and machine sources, manufacturers are empowered to optimize production processes , reduce downtime and boost revenue generation. Combined, these have shown even greater value for early adaptor customers, including a leading USA-based pharmaceutical manufacturer. Today Magazine.

article thumbnail

Is your blood boiling?

Manufacturer's Monthly

Having the barcode and RFID label cuts out mistakes from illegible handwriting, or mistyping labels, making the information system it’s feeding the single source of truth and the written record more of a redundancy. Don’t forget! Temperature sensors are not just limited to healthcare.

article thumbnail

COVID-19 vaccine sales push Moderna past their expectations in Q2 2022

Canadian Manufacturing

The COVID-19 vaccine is Moderna’s main source of revenue, outside of grants and money from collaborations. The company also said it booked another loss and an expense for unused manufacturing capacity due partly to a “substantial reduction” in expected deliveries to the COVAX vaccine-sharing program.

article thumbnail

Reclaiming reality in the digital age

E&T

It’s a paradox that intrigues Sherwood, one that lies at the root of why she wrote her new book ‘Authenticity’ and subtitled it ‘Reclaiming reality in a counterfeit culture’. We’ve also sought to impersonate other people for our own advantage, replicate (with varying levels of success) luxury goods, pharmaceuticals and drinks. .